Primary Site >> Pancreatic Cancer
Gene >> CEACAM3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Carcinoembryonic antigen (CEA) in the diagnosis of pancreatic cancer. PMID: 4687879 Ref: Carcinoembryonic antigen in serum in diseases of the liver and pancreas. PMID: 4727056 Ref: Proceedings: Can carcinoembryonic antigen (CEA) differentiate carcinoma pancreas from chronic pancreatitis? PMID: 4758696 |
Ref: Carcinoma of the pancreas. Detection and monitoring by carcinoembryonic antigen (CEA) and ultrasonography. PMID: 4447096 |
Ref: Migration of peripheral leukocytes in the presence of carcinoembryonic antigen. Studies in patients with chronic inflammatory diseases of the intestine and carcinoma of the colon and pancreas (32568). PMID: 1121500 Ref: [Clinical use of carcinoembryonic antigen (CEA) determination]. PMID: 1212528 |
Ref: [Clinical significance of CEA determination in the diagnosis of pancreatic carcinoma]. PMID: 65872 Ref: Carcinoembryonic antigen (CEA) activity in pancreatic juice of patients with pancreatic carcinoma and pancreatitis. PMID: 1000475 Ref: The present status of carcinoembryonic antigen (CEA) in diagnosis, detection of recurrence, prognosis and evaluation of therapy of colonic and pancreatic cancer. PMID: 1022377 Ref: Carcinoembryonic antigen: clinical and historical aspects. PMID: 1247968 Ref: CEA levels in fluids bathing gastrointestinal tumors. PMID: 1254136 |
Ref: Carcinoembryonic antigen levels in pancreatic carcinoma. PMID: 869334 Ref: Prospective evaluation of the pancreatic secretion of immunoreactive carcinoembryonic antigen, enzyme, and bicarbonate in patients suspected of having pancreatic cancer. PMID: 892342 Ref: The CEA concentration in duodenal fluid in patients with pancreatic disease. PMID: 929116 |
Ref: [The significance of beta2-microglobulin and carcinoembryonic antigen in the diagnosis of the carcinoma of the pancreas (author's transl)]. PMID: 76694 Ref: Studies on an oncofetal antigen, POA. PMID: 101295 Ref: Identification of a macromolecule containing an anticarcinoembryonic antigen-reactive substance and immunoglobulin M in human pancreatic cancer. PMID: 280707 Ref: The use and abuse of CEA test in clinical practice. PMID: 416901 Ref: The value of diagnostic aids in detecting pancreas cancer. PMID: 638974 Ref: Circulating carcinoembryonic antigen in pancreatic carcinoma. PMID: 709516 Ref: Initial levels of CEA and their rate of change in pancreatic carcinoma following surgery chemotherapy and radiation therapy. PMID: 709517 |
Ref: Extraction and identification of a human pancreatic-tumor-associated antigen. PMID: 112519 Ref: Clinical studies on carcinoembryonic antigen in pancreatic cancer. PMID: 221303 |
Ref: Immunological diagnosis of pancreatic cancer by assaying carcinoembryonic antigen (CEA) in pure pancreatic juice. PMID: 7203382 Ref: Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma. PMID: 7227711 Ref: The diagnostic value of plasma carcinoembryonic antigen (CEA) in pancreatic disease. Medical Research Council Tumour Products Committee: Clinical Subgroup. PMID: 7426321 Ref: CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure. PMID: 7461595 |
Ref: Galactosyltransferase isoenzyme II in the detection of pancreatic cancer: comparison with radiologic, endoscopic, and serologic tests. PMID: 6163985 Ref: Tumor markers of pancreatic carcinoma. PMID: 6168354 Ref: Production of antibodies against antigens released from human pancreatic tumour xenografts. PMID: 6169359 Ref: Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft. PMID: 6944528 Ref: Diagnosis of pancreatic cancer by pancreatic oncofetal antigen (poa) in pure pancreatic juice. PMID: 7216142 Ref: Factors controlling the circulating CEA levels in pancreatic cancer: some clinical correlations. PMID: 7272912 Ref: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. PMID: 7284971 Ref: [The value of poly-C-specific serum ribonuclease and CEA in the diagnosis of pancreatic carcinoma (author's transl)]. PMID: 7311390 Ref: [Evaluation of carcinoembryonic antigen (CEA) in patients with neoplasms and hematologic diseases]. PMID: 7340729 |
Ref: Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer. PMID: 6178498 Ref: Coproduction of carcinoembryonic antigen and nonspecific cross-reacting antigen by a continuous cell line from a human pancreatic tumor. PMID: 6810002 Ref: The role of Tennessee antigen in the diagnosis of gastrointestinal malignancy. PMID: 6951548 Ref: Diagnosis of carcinoma of the pancreas by assay of immunosuppressive acidic protein. PMID: 7071823 Ref: Identification of carcinoembryonic antigen (CEA) in bile of patients with malignant biliary tract disease. PMID: 7131963 |
Ref: Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. PMID: 6188527 Ref: [Carcinoembryonic antigen (CEA), serum amylase and pancreozymin-secretin test in relation to stages of pancreatic cancer]. PMID: 6195362 Ref: Serum pancreatic oncofetal antigen: its clinical usefulness for screening pancreatic cancer in combination with tests for other tumor markers. PMID: 6197338 Ref: Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium. PMID: 6317508 Ref: Immunological comparison of carcinoembryonic antigen (CEA) extracted from tumours of various organs: their use in radioimmunological CEA determinations. PMID: 6407507 Ref: Delayed-type cutaneous hypersensitivity to Thomsen-Friedenreich (T) antigen in patients with pancreatic cancer. PMID: 6621025 Ref: Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer. PMID: 6627206 Ref: Establishment and characterization of a carcinoembryonic antigen (CEA)-producing cell line from a human carcinoma of the exocrine pancreas. PMID: 6821838 Ref: Cytologic examination and CEA measurement in aspirated pancreatic material collected by percutaneous fine-needle aspiration biopsy under ultrasonic guidance for the diagnosis of pancreatic carcinoma. PMID: 6861105 Ref: [Recent progress in tumor markers of the digestive system]. PMID: 6876437 |
Ref: [Arterial administration of SMANCS and other antitumor agents dissolved in lipiodol for various malignant solid tumors]. PMID: 6095018 Ref: [Clinical usefulness of serum procollagen-III-peptide in patients with solid tumor]. PMID: 6204598 Ref: [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract]. PMID: 6204834 Ref: Establishment of a human pancreatic cancer cell line and detection of pancreatic cancer associated antigen. PMID: 6205469 Ref: Plasma carcinoembryonic antigen and acinar cell carcinoma of the pancreas. PMID: 6318961 Ref: Values of serum carcinoembryonic antigen and elastase 1 in diagnosis of pancreatic carcinoma. PMID: 6569013 Ref: [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP]. PMID: 6587133 Ref: Pancreatic juice protein associated with chronic pancreatitis and adenocarcinoma of the pancreas. PMID: 6719028 Ref: [Ultrasonically guided biopsy of mass lesions in the pancreas, liver and gallbladder]. PMID: 6732258 |
Ref: Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen. PMID: 2408729 Ref: Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases. PMID: 2410346 Ref: Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases. PMID: 2411125 Ref: Biodegradable mitomycin C microspheres given intra-arterially for inoperable hepatic cancer. With particular reference to a comparison with continuous infusion of mitomycin C and 5-fluorouracil. PMID: 2412682 Ref: Carbohydrate antigenic determinant (CA 19-9) and other tumor markers in gastrointestinal malignancies. PMID: 2581838 Ref: [Serum levels and clinical evaluation of CA 19-9 in various diseases]. PMID: 2582158 Ref: [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract]. PMID: 2582313 Ref: [Tumor markers of pancreatic cancer]. PMID: 3855615 Ref: The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies. PMID: 3856076 Ref: A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma. PMID: 3857396 Ref: Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma. PMID: 3858272 Ref: [A promising tumor marker CA 19-9 for pancreatic carcinoma: comparison with CEA and elastase 1]. PMID: 3858565 Ref: Determination and significance of a new carbohydrate antigen CA19-9 in digestive system cancers. PMID: 3860677 Ref: The significance of CA19-9 tumor antigen in the serum of patients with carcinomas. PMID: 3863154 Ref: Differences in CEA values determined by EIA and RIA in patients with benign and malignant biliary obstructions. PMID: 3887894 Ref: CEA and ferritin in chronic pancreatic disease: a comparative evaluation. PMID: 4018709 Ref: [Gastrointestinal cancer antigen and carcinoembryonic antigen in chronic pancreatopathies and pancreatic tumors]. PMID: 4022426 |
Ref: Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. PMID: 2420441 Ref: Clinical usefulness of three monoclonal antibody-defined tumor markers: CA 19-9, CA 50, and CA 125. PMID: 2437641 Ref: Monoclonal antibodies against CEA-related components discriminate between pancreatic duct type carcinomas and nonneoplastic duct lesions as well as nonduct type neoplasias. PMID: 3004013 Ref: [Circulating immune complexes in patients with malignant neoplasms]. PMID: 3088837 Ref: CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis. PMID: 3456255 Ref: Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. PMID: 3457770 Ref: [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis]. PMID: 3459133 Ref: Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA. PMID: 3467786 Ref: Diagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA. PMID: 3468674 Ref: Tumour markers in pancreatic cancer. PMID: 3470921 Ref: Demonstration of carcinoembryonic antigen (CEA) expression in normal, chronically inflamed, and malignant pancreatic tissue by immunohistochemistry. PMID: 3522636 Ref: Carbohydrate antigen 19-9 (CA 19-9) and carcinoembryonic antigen (CEA) in pancreatic cancer. Role of age and liver dysfunction. PMID: 3530354 Ref: [Biliary carcinoembryonic antigen, non-specific cross-reacting antigen and biliary glycoprotein--their analysis and clinical aspects]. PMID: 3537682 Ref: Noninvasive diagnosis of advanced pancreatic cancer by real-time ultrasonography, carcinoembryonic antigen, and carbohydrate antigen 19-9. PMID: 3554223 Ref: Pancreatic carcinoma in childhood. PMID: 3705961 Ref: [Monoclonal antibody 9A3 raised against a human poorly differentiated gastric adenocarcinoma cell line]. PMID: 3729460 Ref: Is tissue polypeptide antigen more accurate than serum CEA for diagnosing pancreatic cancer? PMID: 3950034 |
Ref: Immuno-histochemical investigations with monoclonal antibodies against CEA-related components in chronic pancreatitis and pancreatic carcinoma. PMID: 2437000 Ref: An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancer. PMID: 2439345 Ref: Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases. PMID: 2441731 Ref: Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line. Histological and immunocytochemical analysis of 37 total pancreatectomy specimens. PMID: 2819857 Ref: [An autopsy case of mucin-producing pancreatic cancer]. PMID: 3039196 Ref: Estrogen and progesterone receptor determination in the papillary cystic neoplasm of the pancreas. With immunohistochemical and ultrastructural observations. PMID: 3304615 Ref: [Clinicohistopathological and immunohistochemical studies on intrapancreatic spread of pancreatic carcinoma]. PMID: 3306340 Ref: Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system. PMID: 3471687 Ref: [Serial changes in serum CA 19-9 levels in pancreatic cancer]. PMID: 3476762 Ref: Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor. PMID: 3542187 Ref: Ultrastructural differentiation and CEA expression of butyrate-treated human pancreatic carcinoma cells. PMID: 3575313 |
Ref: Sensitive serum markers for detecting pancreatic cancer. PMID: 2451556 Ref: [Clinical evaluation on an enzyme immunoassay kit for basic fetoprotein (BFP). (2) Comparison and combination of BFP with other tumor markers]. PMID: 2456040 Ref: [The tumor markers CA 19.9, Ca 50 and CEA in the differential diagnosis of pancreatic carcinoma]. PMID: 2456610 Ref: Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen. PMID: 2458203 Ref: Evidence for carboxyl-terminal processing and glycolipid-anchoring of human carcinoembryonic antigen. PMID: 2842340 Ref: [Transarterial chemoembolization in metastatic liver tumor after curative resection of pancreatic cancer]. PMID: 2843113 Ref: Immunohistochemical studies on cystic pancreatic neoplasms. PMID: 2852801 Ref: Immunohistochemistry of human gastrointestinal cancer-associated antigen detected by monoclonal antibody PA 8-15. PMID: 3130361 Ref: Evaluation of the utility of a radioimmunoassay for serum CA 19-9 levels in patients before and after treatment of carcinoma of the pancreas. PMID: 3162513 Ref: A clinical evaluation of monoclonal (CA19-9, CA50, CA12-5) and polyclonal (CEA, TPA) antibody-defined antigens for the diagnosis of pancreatic cancer. PMID: 3163149 Ref: [Assay of serum elastase 1 in adenocarcinoma of the pancreas: diagnostic value, compared and combined study with serum CEA and CA 19-9]. PMID: 3166429 Ref: Serum carcinoembryonic antigen in the differential diagnosis of pancreatic cancer: influence of tumour spread, liver impairment, and age. PMID: 3168400 Ref: An evaluation of serum CA 50 levels in cancer using a time-resolved fluoroimmunoassay. PMID: 3179405 Ref: Limits of CEA and ferritin in the diagnosis of pancreatic cancer. PMID: 3209864 Ref: Production of monoclonal antibodies to serum antigens in colorectal carcinoma. PMID: 3286775 Ref: [Oncofetal proteins--new developments]. PMID: 3291769 Ref: Immunohistochemical localization of CA 19-9 and CEA in pancreatic carcinoma and associated diseases. PMID: 3422034 |
Ref: Serum levels of CA 125 in patients with gastrointestinal cancers. PMID: 2480631 Ref: Serum ribonuclease and its isoenzymes for diagnosis of pancreatic cancer. PMID: 2503304 Ref: [Boron neutron capture therapy using 10B entrapped anti-CEA immunoliposome]. PMID: 2519218 Ref: Duct-islet cell tumor of the pancreas. A case report with immunohistochemical and electron microscopic findings. PMID: 2558493 Ref: [Clinical evaluation of serum sialyl SSEA-1 (SLX) in diagnosis of cancers]. PMID: 2571740 Ref: [Clinical relevance of tumor markers]. PMID: 2672606 Ref: [An autopsied case of malignant lymphoma of the pancreas with an elevation of the serum Ca 19-9 level]. PMID: 2691718 Ref: [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer]. PMID: 2730018 Ref: Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. PMID: 2736232 Ref: Tumor marker secretion (CA 19-9, CEA, CA 125) by xenografts of eight different human pancreatic carcinomas compared to the human tumors. PMID: 2749476 Ref: [Tumor markers in the upper intestinal tract--stomach and pancreas]. PMID: 2773485 Ref: Comparison of serum CA 19-9 and CEA levels in a population at high risk for colorectal cancer. PMID: 2807313 Ref: Comparison of CA 72-4 with CA 19-9 and carcinoembryonic antigen in the serodiagnostics of gastrointestinal malignancies. PMID: 2814339 Ref: Expression of monoclonal antibody-defined tumor markers in four carcinomas. PMID: 2916833 |
Ref: Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis. PMID: 1689141 Ref: Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2. PMID: 1696288 Ref: Radioimmunolocalization of tumours of the pancreas and biliary tree. PMID: 2078788 Ref: Evaluation of non-invasive diagnostic tests in detecting cancer of the pancreas. PMID: 2125254 Ref: Review of pancreatic cancer. PMID: 2135640 Ref: [Study on the clinical usefulness of NCC-ST-439 in cases of digestive tract cancer]. PMID: 2212836 Ref: Cell lineage markers in human pancreatic cancer. PMID: 2224768 Ref: Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer. PMID: 2230355 Ref: [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations]. PMID: 2264338 Ref: Tumor markers in pancreatic cancer: a comparative clinical study between CEA, CA 19-9 and CA 50. PMID: 2286776 Ref: Usefulness of a new tumor marker, Span-1, for the diagnosis of pancreatic cancer. PMID: 2311067 Ref: D-14 monoclonal antibody to carcinoembryonic antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human colorectal carcinoma, tumors of non-colorectal origin and normal tissues. PMID: 2312605 Ref: Polyamine concentrations in pancreatic tissue, serum, and urine of patients with pancreatic cancer. PMID: 2315288 Ref: [Antigens associated with cancer of the pancreas]. PMID: 2317577 Ref: Serum CA 12-5 concentrations and CA 12-5/CEA ratios in patients with epithelial ovarian cancer. PMID: 2355747 Ref: Detection of tumor associated antigen, PA8-15, in sera from pancreatic and gastrointestinal carcinoma patients. PMID: 2370693 |
Ref: Labelled antibody imaging in pancreatic cancer, cholangiocarcinoma, chronic pancreatitis and sclerosing cholangitis. PMID: 1651876 Ref: [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs]. PMID: 1709347 Ref: Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer. PMID: 1720884 Ref: Tumor-associated trypsin inhibitor in pancreatic diseases. PMID: 1723534 Ref: [The clinical information value of an immunoenzyme study of the tumor markers CA-19-9, CEA and AFP in cancer of the stomach, pancreas, colon and rectum]. PMID: 1726842 Ref: [Circulating "tumor markers" in gastrointestinal tumors]. PMID: 1758235 Ref: Role of local and systemic factors in increasing serum glycoprotein markers of pancreatic cancer. PMID: 1770322 Ref: Evaluation of TATI and other markers in solid tumors. PMID: 1780686 Ref: Evaluation of CEA, CA 19-9, CA-50, CA-195, and TATI with special reference to pancreatic disorders. PMID: 1791319 Ref: Lymphoepithelial cyst of the pancreas. Clinical, morphological, and immunohistochemical findings. PMID: 1801913 Ref: [Role of carcinoembryonic antigen, carbohydrate antigen 19-9 and cytology of bile in diagnosis of biliary and pancreatic cancer]. PMID: 1886576 Ref: Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. PMID: 1890143 Ref: Scintigraphic detection of gastric and pancreatic carcinomas with In-111 ZCE 025 monoclonal antibody. PMID: 1994596 Ref: Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma. PMID: 1995358 Ref: [Serum carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) values in patients with pancreatic cancer or pancreatitis]. PMID: 2039968 Ref: [Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma]. PMID: 2047559 Ref: The possibility of diagnosing small pancreatic cancer (less than 4.0 cm) by measuring various serum tumor markers. A retrospective study. PMID: 2049735 Ref: Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9. PMID: 2072697 |
Ref: A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients. PMID: 1295478 Ref: Surgical treatment of periampullary cancer--review of 766 surgical experiences of 8 hospitals. PMID: 1299231 Ref: [Value of plasma testosterone, carcinoembryonic antigen and CA 19-9 in the differential diagnosis of pancreatic carcinoma and chronic pancreatitis]. PMID: 1300550 Ref: Duct-acinar-islet cell tumor of the pancreas. PMID: 1316659 Ref: Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma. PMID: 1316775 Ref: Comparative analysis of CA72-4, CA195 and carcinoembryonic antigen in patients with gastrointestinal malignancies. PMID: 1374412 Ref: Correlation between CA19-9 production in vitro and histological grades of differentiation in vivo in clones isolated from a human pancreatic cancer cell line (SUIT-2). PMID: 1391733 Ref: The prognostic value of the tumour markers CA 195 and CEA in patients with adenocarcinoma of the pancreas. PMID: 1426303 Ref: [The immunological indices in inflammatory and tumorous diseases of the pancreas]. PMID: 1509377 Ref: Treatment of duct carcinoma of the pancreas with the LH-RH analogue buserelin. PMID: 1513800 Ref: Present status of periampullary cancer treatment in Korea. PMID: 1514830 Ref: Carcinoembryonic antigen assay in fine needle aspirate of pancreas: a diagnostic adjunct to cytology. PMID: 1553944 Ref: [Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology]. PMID: 1603581 Ref: Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. PMID: 1739620 |
Ref: Variability in cyst fluid carcinoembryonic antigen level, fluid viscosity, amylase content, and cytologic findings among multiple loculi of a pancreatic mucinous cystic neoplasm. PMID: 7692722 Ref: Release of carcinoembryonic antigen from human tumor cells by phosphatidylinositol-specific phospholipase C: highly effective extraction and upregulation from LS-174T colonic adenocarcinoma cells. PMID: 8215392 Ref: Clinical evaluation of tissue polypeptide antigen (TPA) in the diagnosis of pancreatic carcinoma. PMID: 8267397 Ref: Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer. PMID: 8302789 Ref: The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study. PMID: 8317910 Ref: [Two cases of improved quality of life with intra-arterial infusion of CDDP or unresectable gallbladder and pancreatic cancer]. PMID: 8373246 Ref: Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. PMID: 8383029 Ref: CA 242 is a new tumor marker for pancreatic cancer. PMID: 8431849 Ref: Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study. PMID: 8471445 Ref: Comparative evaluation of serum CA 195 and carcinoembryonic antigen in metastatic carcinoma. PMID: 8490911 Ref: New radioimmunoassay for pancreatic cancer-associated antigen span-1 with reference to differential-diagnosis and monitoring in pancreatic-cancer. PMID: 21573647 |
Ref: The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer. PMID: 7510116 Ref: Pancreas cancer-associated antigen (PCAA) in medullary thyroid carcinoma. PMID: 7609706 Ref: [Diagnostic strategy for malignancy and parenchymal invasion of so-called mucin-producing tumor of the pancreas]. PMID: 7815723 Ref: [A case of mediastinal mature teratoma presenting increased serum CA19-9 level]. PMID: 7836831 Ref: Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer. PMID: 7846017 Ref: Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages. PMID: 7846018 Ref: [Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma]. PMID: 7851144 Ref: [Clinical usefulness of tumor markers associated with pancreatic cancer]. PMID: 7908065 Ref: Directed enzyme pro-drug gene therapy for pancreatic cancer in vivo. PMID: 8047987 Ref: CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. PMID: 8080735 Ref: A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnos PMID: 8123488 Ref: Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma. PMID: 8146530 Ref: Pancreatic cystic islet-cell tumors. Clinical and pathologic features in two cases with cyst fluid analysis. PMID: 8195644 Ref: Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma. PMID: 8207049 |
Ref: Tissue polypeptide-specific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours. PMID: 7529527 Ref: A case of pleomorphic carcinoma of the pancreas showing sequential histological change by immunohistochemical study. PMID: 7594772 Ref: Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice. PMID: 7634181 Ref: [Immunocytologic detection of micro-metastatic cells in patients with gastrointestinal tumors]. PMID: 7709662 Ref: [Spontaneous rupture of the ureter caused by metastatic ureteric tumor: a case report]. PMID: 7900570 Ref: Serum CA 242 in pancreatic cancer. Comparison with CA 19-9 and CEA. PMID: 8562994 |
Ref: Phase II study of gemcitabine in patients with advanced pancreatic cancer. PMID: 8554969 Ref: Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis. PMID: 8591850 Ref: Improved tumor detection by anti-CEA chimeric Fab oligomers with disulfide linkages in a pancreatic-carcinoma-xenograft model. PMID: 8603822 Ref: Tumor markers in patients with pancreatic carcinoma. PMID: 8646727 Ref: [Pancreatic carcinoma: diagnosis]. PMID: 8685856 Ref: Treatment of advanced pancreatic cancer with mistletoe: results of a pilot trial. PMID: 8687151 Ref: Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon. PMID: 8694564 Ref: A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700. PMID: 8704058 Ref: Solid and papillary neoplasms of the pancreas. PMID: 8711936 Ref: CA 19.9, CA 242 and CEA in the diagnosis and follow-up of pancreatic cancer. PMID: 8776607 Ref: Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients. PMID: 8950323 |
Ref: Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. PMID: 9043021 Ref: Ki-ras mutations and the carcinoembryonic antigen level in fine needle aspirates of the pancreas. PMID: 9100777 Ref: Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts. PMID: 9128321 Ref: Clinical significance of serum p53 antigen in patients with pancreatic carcinomas. PMID: 9203945 Ref: [A case of unresectable pancreatic cancer successfully treated with continuous venous daily infusion of 5-FU and low-dose CDDP]. PMID: 9212814 Ref: Immunotherapy of cancer. Generation of CEA specific CTL using CEA peptide pulsed dendritic cells. PMID: 9286413 Ref: Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells. PMID: 9287985 Ref: [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases]. PMID: 9432648 |
Ref: Intraductal neoplasms of the pancreas. PMID: 9600293 Ref: In vivo adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing pancreatic cancer. PMID: 9617353 Ref: Clinical usefulness of CA-19-9 in pancreatic carcinoma. PMID: 9671952 Ref: Tumor markers in evaluating the response to radiotherapy in unresectable pancreatic cancer. PMID: 9684148 Ref: Advanced pancreatic cancer successfully treated with continuous infusion of 5-fluorouracil and low-dose cisplatin. PMID: 9711896 Ref: FNAC guided by computed tomography in the diagnosis of primary pancreatic adenosquamous carcinoma. A report of three cases. PMID: 9850660 Ref: Pre-operative predictors of short-term survival after pancreatic cancer resection. PMID: 9951931 Ref: Pancreatic cancer and fibrinogen storage disease. PMID: 10193333 Ref: A clinical evaluation of serological diagnosis for pancreatic cancer. PMID: 11819260 |
Ref: Enhancement of tumor uptakes by stabilized Fab homo-oligomers of a chimeric monoclonal antibody against carcinoembryonic antigen. PMID: 9863020 Ref: Comparative study of carbohydrate antigen 195 and carcinoembryonic antigen for the diagnosis of pancreatic carcinoma. PMID: 9933690 Ref: Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis. PMID: 10205291 Ref: Intrapancreatic accessory spleen. A rare cause of a pancreatic mass. PMID: 10211424 Ref: Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy. PMID: 10228761 Ref: Doubling time of serum CA 19-9 in the clinical course of patients with pancreatic cancer and its significant association with prognosis. PMID: 10404129 Ref: Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancer. PMID: 10414697 Ref: Tumor specific CTL therapy for advanced cancer and development for cancer vaccine. PMID: 10429976 Ref: CA 242 in comparison with established tumour markers in colorectal, pancreatic and lung cancer. PMID: 10470177 Ref: [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer]. PMID: 10535205 Ref: High serum concentrations of sialyl Tn antigen in carcinomas of the biliary tract and pancreas. PMID: 10664288 Ref: Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker. PMID: 10697625 Ref: [A clinicopathological study of pancreatoblastoma]. PMID: 11869544 |
Ref: Nonfunctioning islet cell carcinoma of the pancreas with high serum CEA & CA19-9, K-ras codon 12 mutation, and microsatellite instability. PMID: 10777194 Ref: Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer. PMID: 10982594 Ref: CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging. PMID: 11096345 Ref: The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma. PMID: 11149048 Ref: [Monoclonal antibody SPan-1 in the diagnosis of exocrine pancreatic adenocarcinoma]. PMID: 11190527 Ref: Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies. PMID: 11326643 Ref: [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy]. PMID: 11798763 |
Ref: Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multipl PMID: 11289125 Ref: [Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer]. PMID: 11544826 Ref: SPan-1 and exocrine pancreatic carcinoma. The clinical role of a new tumor marker. PMID: 11605732 Ref: Pancreatic granular cell tumor combined with carcinoma in situ. PMID: 11844055 Ref: Cytoreductive surgery combined with intraoperative chemo-hyperthermia and postoperative radiotherapy in the management of advanced pancreatic adenocarcinoma: feasibility aspects and efficacy. PMID: 11956909 Ref: Role of endoscopic ultrasound in the diagnosis of cystic lesions of the pancreas. PMID: 12120247 Ref: Laparoscopic peritoneal lavage cytology and immunocytology in pancreatic and periampullary carcinoma. PMID: 18333016 |
Ref: Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. PMID: 11986188 Ref: Intraoperative hyperthermia and chemoradiotherapy for inoperable pancreatic carcinoma. PMID: 12099945 Ref: CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. PMID: 12174919 Ref: Regulation of herpes simplex virus 1 replication using tumor-associated promoters. PMID: 12368679 Ref: The value of standard serum tumor markers in differentiating mucinous from serous cystic tumors of the pancreas: CEA, Ca 19-9, Ca 125, Ca 15-3. PMID: 12447553 Ref: The feasibility and safety of immunotherapy with dendritic cells loaded with CEA mRNA following neoadjuvant chemoradiotherapy and resection of pancreatic cancer. PMID: 12630764 |
Ref: Peripancreatic artery ligation and artery infusion chemotherapy for advanced pancreatic carcinoma. PMID: 12667396 Ref: Ductal adenocarcinoma of the pancreas with huge cystic degeneration: a lesion to be distinguished from pseudocyst and mucinous cystadenocarcinoma. PMID: 12894360 Ref: [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment]. PMID: 14518416 Ref: Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer. PMID: 14571813 Ref: Potentiation of ionising radiation by targeting tumour necrosis factor alpha using a bispecific antibody in human pancreatic cancer. PMID: 14612914 Ref: [Gemcitabine infusion via splenic artery for advanced pancreatic cancer]. PMID: 14619495 Ref: [Tumoral markers and acute-phase reactants in the diagnosis of pancreatic cancer]. PMID: 14670235 Ref: The role of bile carcinoembryonic antigen in diagnosing bile duct cancer. PMID: 14676443 Ref: [Histopathology and tumor markers]. PMID: 14743744 Ref: Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer. PMID: 14981971 Ref: [Usefulness of preoperative assay of arginase in pancreatic cancer patients]. PMID: 15058249 |
Ref: Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes. PMID: 14681723 Ref: A bispecific antibody to enhance radiotherapy by tumor necrosis factor-alpha in human CEA-expressing digestive tumors. PMID: 14751531 Ref: Dendritic cells pulsed with pancreatic cancer total tumor RNA generate specific antipancreatic cancer T cells. PMID: 15036193 Ref: [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas]. PMID: 15164602 Ref: Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses. PMID: 15173089 Ref: Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions. PMID: 15239993 Ref: Role of endoscopic ultrasonography in the diagnosis and treatment of cystic tumors of the pancreas. PMID: 15254361 Ref: [Intra-arterial cellular immunochemotherapy for unresectable pancreatic cancer with liver metastasis]. PMID: 15553704 Ref: Alexa Fluor 488-conjugated anti-carcinoembryonic antigen monoclonal antibody PMID: 20641682 |
Ref: Panniculitis after vaccination against CEA and MUC1 in a patient with pancreatic cancer. PMID: 15629278 Ref: [Pancreatic ductal adenocarcinoma and its precursors]. PMID: 15630571 Ref: The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer. PMID: 15698733 Ref: [A case of unresectable advanced pancreatic tail cancer successfully treated with gemcitabine hydrochloride]. PMID: 15751642 Ref: Pancreatectomy using the no-touch isolation technique followed by extensive intraoperative peritoneal lavage to prevent cancer cell dissemination: a pilot study. PMID: 15767730 Ref: [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer]. PMID: 15984518 Ref: Further evidence for prolongation of survival of pancreatic cancer patients by efficacy orientated sequential polychemotherapy (EOSPC) based on serial tumor marker determinations (CA 19-9/CEA). PMID: 16033083 Ref: Difficulty with diagnosis of malignant pancreatic neoplasms coexisting with chronic pancreatitis. PMID: 16124071 Ref: Novel serum tumor marker, RCAS1, in pancreatic diseases. PMID: 16127752 Ref: Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. PMID: 16183479 Ref: EIPL (extensive intraoperative peritoneal lavage) therapy significantly reduces peritoneal recurrence after pancreatectomy in patients with pancreatic cancer. PMID: 16211228 Ref: [The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers]. PMID: 16255879 Ref: Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma. PMID: 16425381 |
Ref: [Pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasms (IPMN)]. PMID: 16637385 Ref: Differential gene expression in patients genetically predisposed to pancreatic cancer. PMID: 16815451 Ref: [Clinical analysis of 9 cases of solid-cystic pseudopapillary tumor of the pancreas with literature review]. PMID: 17059778 Ref: ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. PMID: 17060676 Ref: [Cutaneous metastases from adenocarcinoma of unknown primary site]. PMID: 17173831 |
Ref: Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. PMID: 17222396 Ref: CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice. PMID: 17262731 Ref: Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. PMID: 17417647 Ref: Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies. PMID: 17424828 Ref: Reflections on treatment strategies for palliative chemotherapy of pancreatic cancer. PMID: 17649774 Ref: ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. PMID: 17764489 Ref: Endoscopic ultrasound-guided fine-needle aspiration cytology diagnosis of solid pseudopapillary tumor of the pancreas: a case report and literature review. PMID: 17876886 Ref: Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer. PMID: 18039393 Ref: Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. PMID: 18040617 Ref: Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head. PMID: 18086633 Ref: Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. PMID: 18251127 |
Ref: Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting. PMID: 18077530 Ref: Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. PMID: 18154768 Ref: Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management. PMID: 18330959 Ref: A case of invasive hemolymphangioma of the pancreas. PMID: 18473426 Ref: Sporadic pancreatic polypeptide secreting tumors (PPomas) of the pancreas. PMID: 18521664 Ref: TPS, CA 19-9, VEGF-A, and CEA as diagnostic and prognostic factors in patients with mass lesions in the pancreatic head. PMID: 18521799 Ref: Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. PMID: 18594015 Ref: [A case of advanced pancreatic cancer successfully treated by combined chemotherapy of S-1 and gemcitabine]. PMID: 18633272 Ref: Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer. PMID: 18665430 Ref: [A case of advanced gastric cancer successfully treated with S-1 and paclitaxel followed by curative resection]. PMID: 18701853 Ref: Value of ultrasound examination in differential diagnosis of pancreatic lymphoma and pancreatic cancer. PMID: 19034981 |
Ref: A case of osteoclast-like giant cell tumor of the pancreas associated with borderline mucinous cystic neoplasm. PMID: 18493871 Ref: Fine-needle aspiration of cystic pancreatic mucinous tumor: oncotic cell as an aiding diagnostic feature in paucicellular specimens. PMID: 19021219 Ref: Invasive ductal carcinoma of the pancreas showing exophytic growth. PMID: 19208524 Ref: Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. PMID: 19380648 Ref: Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer. PMID: 19470732 Ref: Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management. PMID: 19536601 Ref: Pancreatic carcinoma with multilineage (acinar, neuroendocrine, and ductal) differentiation. PMID: 19636408 Ref: Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection. PMID: 19763694 Ref: Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patients. PMID: 19798410 Ref: Clear cell carcinoma of the pancreas--a case report and review of the literature. PMID: 19809568 Ref: Identification of a biomarker panel using a multiplex proximity ligation assay improves accuracy of pancreatic cancer diagnosis. PMID: 20003342 Ref: Prognostic value of CRM1 in pancreas cancer. PMID: 20003838 Ref: [A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy]. PMID: 20037442 Ref: En bloc resection for right colon cancer directly invading duodenum or pancreatic head. PMID: 20046421 Ref: CEA and CA-19.9 serum tumor markers as prognostic factors in patients with locally advanced (unresectable) or metastatic pancreatic adenocarcinoma: a retrospective analysis. PMID: 20071292 Ref: Clinical application of tumour markers: a review. PMID: 21591514 Ref: Markedly elevated CA19-9 associated with benign ovarian cyst and ascites. PMID: 21686409 |
Ref: Elevated levels of CA 19-9 and CEA in pancreatic cancer-associated diabetes. PMID: 20174821 Ref: Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010. PMID: 20208319 Ref: Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. PMID: 20394436 Ref: [Minimal residual disease in pancreatic cancer--our first experiences]. PMID: 20429336 Ref: Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer. PMID: 20480409 Ref: Pancreatic metastasis from colon carcinoma nine years after a hemicolectomy managed by distal pancreatectomy. A review of the literature regarding the role and outcome of pancreatic resection for colorectal metastasis. PMID: 20601814 Ref: Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis. PMID: 20626020 Ref: [Possibility of using the determination of minimal residual disease in pancreatic adenocarcinoma using real-time RT-PCR--a pilot study]. PMID: 20662469 Ref: [Significance of serum tumor markers monitoring metastases in carcinomas of unknown primary site]. PMID: 20954411 Ref: Staining for p53 and Ki-67 increases the sensitivity of EUS-FNA to detect pancreatic malignancy. PMID: 21173913 Ref: Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies. PMID: 21560524 |
Ref: Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience. PMID: 20737567 Ref: Marker expression in circulating cancer cells of pancreatic cancer patients. PMID: 20869080 Ref: Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. PMID: 21193998 Ref: K-ras mutations correlate with atypical cytology and elevated CEA levels in pancreatic cystic neoplasms. PMID: 21264513 Ref: Carbohydrate markers of pancreatic cancer. PMID: 21265800 Ref: Predictive value of serum carbohydrate antigen 19-9 in malignant intraductal papillary mucinous neoplasms. PMID: 21416173 Ref: CT diagnosis of recurrence after pancreatic cancer: is there a pattern? PMID: 21448416 Ref: Pancreatic cancer surgery in the new millennium: better prediction of outcome. PMID: 21606835 Ref: Serum APRIL, a potential tumor marker in pancreatic cancer. PMID: 21612541 Ref: Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. PMID: 21717311 Ref: Metastatic medullary thyroid cancer presenting with elevated levels of CA 19-9 and CA 125. PMID: 21751886 Ref: Targeting CEA in Pancreas Cancer Xenografts with a Mutated scFv-Fc Antibody Fragment. PMID: 22214289 |
Ref: Guide to diagnosing primary pancreatic lymphoma, B-cell type: immunocytochemistry improves the diagnostic accuracy of endoscopic ultrasonography-guided fine needle aspiration cytology. PMID: 21416645 Ref: Evaluation of CA 242 as a tumor marker in gallbladder cancer. PMID: 21573879 Ref: The efficacy evaluation of cryosurgery in pancreatic cancer patients with the expression of CD44v6, integrin-beta1, CA199, and CEA. PMID: 22382453 Ref: Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-alpha and TSGF after cryosurgery in pancreatic cancer patients. PMID: 22456901 Ref: Efficacy of carcinogenic embryonic antigen in differential diagnosis of diseases of pancreas and liver--a comparative study in a tertiary care hospital of Western Nepal. PMID: 22502684 Ref: Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study. PMID: 22517701 Ref: Levels of CEA and Ca 19 - 9 in the sera and peritoneal cavity in patients with gastric and pancreatic cancers. PMID: 22666759 Ref: Pancreatic large mucinous cystoadenoma with invasive ductal carcinoma in pregnancy. Case report. PMID: 22709451 Ref: betaig-h3 supports gastric cancer cell adhesion, migration and proliferation in peritoneal carcinomatosis. PMID: 22710407 Ref: Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer. PMID: 22797386 Ref: Comparison of serum tumor associated material (TAM) with conventional biomarkers in cancer patients. PMID: 22901228 Ref: Dermokine expression in intraductal papillary-mucinous neoplasm and invasive pancreatic carcinoma. PMID: 23060565 Ref: A case of multiple primary malignancies and investigation of family history. PMID: 23162625 Ref: Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistance. PMID: 23205084 Ref: CAR's made it to the pancreas. PMID: 23243602 Ref: [A case of postoperative liver metastasis from pancreatic carcinoma treated with percutaneous isolated hepatic perfusion(PIHP)]. PMID: 23267919 |
Ref: T cells redirected by a CD3zeta chimeric antigen receptor can establish self-antigen-specific tumour protection in the long term. PMID: 22378346 Ref: Occult tumour cells in peritoneal lavage are a negative prognostic factor in pancreatic cancer. PMID: 23128819 Ref: Mucinous cystic neoplasm of the pancreas with neuroendocrine cells and malignant stroma. PMID: 23299164 Ref: Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy. PMID: 23315099 Ref: The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. PMID: 23331006 Ref: A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes. PMID: 23506840 Ref: Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. PMID: 23549809 Ref: Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin. PMID: 23568978 Ref: Pancreatic cancer in Saudi patients treated at tertiary institution. Ten years retrospective study. PMID: 23756925 Ref: [A comparative study on serum immunoglobulin and tumor marker levels in the patients with autoimmune pancreatitis and pancreatobiliary malignancies]. PMID: 23877213 Ref: MicroRNA from pancreatic duct aspirate differentiates cystic lesions of the pancreas. PMID: 23884752 Ref: Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9. PMID: 23949878 Ref: CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer. PMID: 24146342 Ref: [Latest advances in pancreatic tumors]. PMID: 24160958 Ref: Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study. PMID: 24161419 Ref: [Two cases reports of pancreatic endocrine microadenoma incidentally found]. PMID: 24331723 Ref: Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival. PMID: 24649248 Ref: A randomized pilot phase I study of modified carcinoembryonic antigen (CEA) peptide (CAP1-6D)/montanide/GM-CSF-vaccine in patients with pancreatic adenocarcinoma. PMID: 24829746 Ref: Surgical management and results for cystic neoplasms of pancreas. PMID: 26155225 |
Ref: A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and alpha fetoprotein and their associations with cancer risk. PMID: 23300138 Ref: Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients. PMID: 24114022 Ref: Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice. PMID: 24373959 Ref: Evaluation of prognostic factors and survival results in pancreatic carcinomas in Turkey. PMID: 24377570 Ref: Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer. PMID: 24523528 Ref: Adjuvant therapy for pancreatic cancer. PMID: 24618424 Ref: Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy. PMID: 24647734 Ref: Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. PMID: 24747429 Ref: Predicting factors for unresectability in patients with pancreatic ductal adenocarcinoma. PMID: 24764208 Ref: Diagnosis of pancreatic carcinoma based on combined measurement of multiple serum tumor markers using artificial neural network analysis. PMID: 24824251 Ref: Expression of RUNX3 gene in pancreatic adenocarcinoma and its clinical significance. PMID: 24938604 Ref: Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions. PMID: 25003676 Ref: Adult pancreatic hemangioma: A case report. PMID: 25013478 Ref: Surgical resection and outcome of pancreatic cystic neoplasms in China: analysis of a 16-year experience from a single high-volume academic institution. PMID: 25037860 Ref: Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma. PMID: 25106741 Ref: Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels. PMID: 25278306 Ref: Primary clear cell ductal adenocarcinoma of the pancreas: a case report and clinicopathologic literature review. PMID: 25313783 Ref: Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells. PMID: 25364454 Ref: Multiple tumor marker protein chip detection system in diagnosis of pancreatic cancer. PMID: 25381564 Ref: Prognostic factors affecting survival after pancreaticoduodenectomy for pancreatic adenocarcinoma (single center experience). PMID: 25436321 |
Ref: A preoperative serum signature of CEA+/CA125+/CA19-9 >/= 1000 U/mL indicates poor outcome to pancreatectomy for pancreatic cancer. PMID: 25273947 Ref: Clinical features and outcome of primary pancreatic lymphoma. PMID: 25341750 Ref: Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. PMID: 25486903 Ref: Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma. PMID: 25729247 Ref: Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer. PMID: 25759406 Ref: Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models. PMID: 25799527 Ref: Analysis of cyst size and tumor markers in the management of pancreatic cysts: support for the original Sendai criteria. PMID: 25868415 Ref: [Analysis of the changes of blood glucose after radiotherapy in pancreatic cancer patients associated with diabetes mellitus and their related factors]. PMID: 25877316 Ref: Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model. PMID: 25893411 Ref: Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors. PMID: 25895046 Ref: Cytopathological Analysis of Cyst Fluid Enhances Diagnostic Accuracy of Mucinous Pancreatic Cystic Neoplasms. PMID: 26091476 Ref: Lymphoepithelial cyst of the pancreas mimicking malignant cystic tumor: report of a case. PMID: 26379736 Ref: Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis. PMID: 26380005 Ref: Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy. PMID: 26434876 Ref: Snail transcript levels in diagnosis of pancreatic carcinoma with fine-needle aspirate. PMID: 26510265 Ref: Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. PMID: 26734638 Ref: [Determination of CEA, EGFR and hTERT expression in peritoneal lavage in patients with pancreatic adenocarcinoma using RT - PCR method]. PMID: 26766154 Ref: [A Case of Pancreatic Cancer with Multiple Liver Metastases That Developed Postoperatively and Showed a Complete Response with S-1 Monotherapy]. PMID: 26805116 Ref: Primary leiomyosarcoma of the pancreas: report of a case treated by local excision and review of the literature. PMID: 26943422 Ref: Soluble gC1qR in Blood and Body Fluids: Examination in a Pancreatic Cancer Patient Cohort. PMID: 26973884 |
Ref: Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. PMID: 26123314 Ref: Metal ions doped chitosan-poly(acrylic acid) nanospheres: Synthesis and their application in simultaneously electrochemical detection of four markers of pancreatic cancer. PMID: 26318783 Ref: Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden. PMID: 26745601 Ref: Indications for staging laparoscopy in pancreatic cancer. PMID: 26776846 Ref: Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology. PMID: 26808421 Ref: A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. PMID: 26808546 Ref: Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report. PMID: 27002756 Ref: Levels of soluble LR11/SorLA are highly increased in the bile of patients with biliary tract and pancreatic cancers. PMID: 27079357 Ref: Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery. PMID: 27130234 Ref: Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer. PMID: 27142076 Ref: Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor. PMID: 27149134 Ref: Prognostic impact of carcinoembryonic antigen (CEA) on patients with metastatic pancreatic cancer: A retrospective cohort study. PMID: 27256641 Ref: Development and Evaluation of a Fluorescent Antibody-Drug Conjugate for Molecular Imaging and Targeted Therapy of Pancreatic Cancer. PMID: 27336622 Ref: Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis. PMID: 27639768 Ref: Serum tumor markers not useful in screening patients with pancreatic mucinous cystic lesions associated with malignant changes. PMID: 27733327 Ref: A mixed adenoneuroendocrine carcinoma of the pancreas: a case report. PMID: 27848241 Ref: [Long-Term Survival in Response to Multimodality Therapy in a Patient with Invasive Pancreatic Cancer with Cyst Formation]. PMID: 28133201 Ref: Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. PMID: 28450803 |
Ref: Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer. PMID: 28267695 Ref: Xanthogranulomatous Pancreatitis -A Rare Case Defying Clinical, Radiological and Tumor Marker Diagnostics with a Review of Literature. PMID: 28272682 Ref: Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma. PMID: 28335509 Ref: Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination. PMID: 28375170 Ref: Preoperative Serum Carcinoembryonic Antigen as a Marker for Predicting the Outcome of Three Cancers. PMID: 28469484 Ref: SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery. PMID: 28577721 Ref: Correlation Between Preoperative Serum Carcinoembryonic Antigen Levels and Expression on Pancreatic and Rectal Cancer Tissue. PMID: 28579847 Ref: Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma. PMID: 28638795 Ref: Anticancer activity of salicin and fenofibrate. PMID: 28733879 Ref: Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma. PMID: 28786050 Ref: A prospective study of endoscopic ultrasonography features, cyst fluid carcinoembryonic antigen, and fluid cytology for the differentiation of small pancreatic cystic neoplasms. PMID: 28836521 Ref: Successful treatment with afatinib for pancreatic metastasis of lung adenocarcinoma: a case report. PMID: 29268429 |
Ref: Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass. PMID: 29171983 Ref: The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC). PMID: 29313457 Ref: [Pancreas Bed Recurrence Resection Combined with Celiac and Common Hepatic Arterial Resection after Distal Pancreatectomy for Pancreatic Cancer]. PMID: 29362327 Ref: Systematic review on the role of serum tumor markers in the detection of recurrent pancreatic cancer. PMID: 29366815 Ref: Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots. PMID: 29545609 Ref: Metastasis of the epididymis and spermatic cord from pancreatic adenocarcinoma: A rare entity. Description of a case and revision of literature. PMID: 29633804 Ref: Clean Colorectum at Diagnostic Colonoscopy: Subsequent Detection of Extracolonic Malignancies by Plasma Protein Biomarkers? PMID: 29872358 Ref: Baseline splenic volume as a surrogate marker of FOLFIRINOX efficacy in advanced pancreatic carcinoma. PMID: 29876012 Ref: Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent. PMID: 30051369 Ref: Serum chemokine CXCL-8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR-2, CRP and classical tumor markers (CA 19-9 and CEA). PMID: 30057378 Ref: Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy. PMID: 30103775 Ref: The Levels of Tumor Markers in Pancreatic Neuroendocrine Carcinoma and Their Values in Differentiation Between Pancreatic Neuroendocrine Carcinoma and Pancreatic Ductal Adenocarcinoma. PMID: 30308534 Ref: Repeated mutKRAS ctDNA measurements represent a novel and promising tool for early response prediction and therapy monitoring in advanced pancreatic cancer. PMID: 30346475 Ref: Laparoscopic pancreaticoduodenectomy for metastatic pancreatic melanoma: A case report. PMID: 30383642 |